• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

表皮生长因子受体突变与 IASLC/ATS/ERS 分类下肺腺癌主要组织学亚型的相关性。

Correlation of Epidermal Growth Factor Receptor Mutation With Major Histologic Subtype of Lung Adenocarcinoma According to IASLC/ATS/ERS Classification.

机构信息

Faculty of Medicine and Pharmacy, Laboratory of Biomedical and Translational Research, 314397Sidi Mohamed Ben Abdellah University, Fez, Morocco.

Laboratory of Anatomic Pathology and Molecular Pathology, University Hospital Hassan II, 470521Sidi Mohamed Ben Abdellah University, Fez, Morocco.

出版信息

Cancer Control. 2022 Jan-Dec;29:10732748221084930. doi: 10.1177/10732748221084930.

DOI:10.1177/10732748221084930
PMID:35348028
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8969502/
Abstract

OBJECTIVE

Our prospective study aims to define the correlation of (epidermal growth factor receptor) mutations with major histological subtypes of lung adenocarcinoma from resected and non-resected specimens, according to the WHO 2015 classification, in Moroccan North East Population.

METHODS

mutations of 150 primary lung adenocarcinoma were performed using Real-Time PCR or SANGER sequencing. SPSS 21 was used to assess the relationship between histological subtypes of lung adenocarcinoma and mutation status.

RESULTS

25 mutations were detected in the series of 150 lung adenocarcinomas, most of which were found in cases with papillary, acinar, patterns than without these patterns and more frequently occurred in the cases without solid pattern than with this pattern. A significant correlation was observed between mutation and acinar (P = 0,024), papillary pattern (P = 0,003) and, negative association with a solid pattern (P < 0,001). In females, mutations were significantly correlated with the acinar pattern (P = 0,02), whereas in males with the papillary pattern (P = 0,01). Association between the histologic component and exon 19 deletions and exon 21 mutations were also evaluated and, we found a significant correlation between the papillary major pattern with exon 19 mutations (P = 0,004) and, ex21 with the acinar component (P = 0,03).

CONCLUSION

An analysis of resected and non-resected lung ADC specimens in 150 Moroccan Northeast patients, revealed that acinar and papillary patterns may predict the presence of a mutation in the gene. While the solid major pattern may indicate a low mutation rate of the gene.

摘要

目的

我们的前瞻性研究旨在根据 2015 年世界卫生组织分类,定义(表皮生长因子受体)突变与从切除和未切除标本中分离的肺腺癌主要组织学亚型之间的相关性,在摩洛哥东北地区人群中。

方法

使用实时 PCR 或 SANGER 测序对 150 例原发性肺腺癌进行 突变检测。使用 SPSS 21 评估肺腺癌的组织学亚型与 突变状态之间的关系。

结果

在 150 例肺腺癌系列中检测到 25 种突变,其中大多数在具有乳头状、腺泡样形态的病例中发现,而在没有这些形态的病例中更为常见,并且在没有实体形态的病例中比具有这种形态的病例更频繁发生。在统计学上, 突变与腺泡(P = 0.024)、乳头状模式(P = 0.003)显著相关,与实体模式呈负相关(P < 0.001)。在女性中, 突变与腺泡模式显著相关(P = 0.02),而在男性中与乳头状模式相关(P = 0.01)。还评估了组织学成分与外显子 19 缺失和外显子 21 突变之间的关联,我们发现主要的乳头状模式与外显子 19 突变(P = 0.004)和外显子 21 与腺泡成分之间存在显著相关性(P = 0.03)。

结论

对 150 例摩洛哥东北部患者的切除和未切除肺 ADC 标本进行分析,显示腺泡和乳头状模式可能预测 基因的存在突变。而实体主要模式可能表明 基因的突变率较低。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7d0/8969502/ce0d1c37c1a0/10.1177_10732748221084930-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7d0/8969502/38c95115801a/10.1177_10732748221084930-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7d0/8969502/ce0d1c37c1a0/10.1177_10732748221084930-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7d0/8969502/38c95115801a/10.1177_10732748221084930-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7d0/8969502/ce0d1c37c1a0/10.1177_10732748221084930-fig1.jpg

相似文献

1
Correlation of Epidermal Growth Factor Receptor Mutation With Major Histologic Subtype of Lung Adenocarcinoma According to IASLC/ATS/ERS Classification.表皮生长因子受体突变与 IASLC/ATS/ERS 分类下肺腺癌主要组织学亚型的相关性。
Cancer Control. 2022 Jan-Dec;29:10732748221084930. doi: 10.1177/10732748221084930.
2
Correlation of EGFR mutation status with predominant histologic subtype of adenocarcinoma according to the new lung adenocarcinoma classification of the International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society.根据国际肺癌研究协会/美国胸科学会/欧洲呼吸学会新的肺腺癌分类,EGFR突变状态与腺癌主要组织学亚型的相关性。
Arch Pathol Lab Med. 2014 Oct;138(10):1353-7. doi: 10.5858/arpa.2013-0376-OA. Epub 2014 Feb 26.
3
Associations between epidermal growth factor receptor mutations and histological subtypes of lung adenocarcinoma according to the IASLC/ATS/ERS classification in Chinese patients.表皮生长因子受体突变与中国患者 IASLC/ATS/ERS 分类肺腺癌组织学亚型的相关性。
Thorac Cancer. 2017 Nov;8(6):600-605. doi: 10.1111/1759-7714.12489. Epub 2017 Sep 20.
4
Mutational Profile and New IASLC/ATS/ERS Classification Provide Additional Prognostic Information about Lung Adenocarcinoma: A Study of 125 Patients from Brazil.突变谱与新的国际肺癌研究协会/美国胸科学会/欧洲呼吸学会分类为肺腺癌提供了额外的预后信息:一项对125例巴西患者的研究。
Oncology. 2015;89(3):175-86. doi: 10.1159/000376552. Epub 2015 Apr 1.
5
High incidence of EGFR mutations in Korean men smokers with no intratumoral heterogeneity of lung adenocarcinomas: correlation with histologic subtypes, EGFR/TTF-1 expressions, and clinical features.韩国男性吸烟肺腺癌患者中 EGFR 突变的高发率:与组织学亚型、EGFR/TTF-1 表达及临床特征的相关性,无肿瘤内异质性。
J Thorac Oncol. 2012 Feb;7(2):323-30. doi: 10.1097/JTO.0b013e3182381515.
6
Associations between the IASLC/ATS/ERS lung adenocarcinoma classification and EGFR and KRAS mutations.国际肺癌研究协会(IASLC)/美国胸科学会(ATS)/欧洲呼吸学会(ERS)肺腺癌分类与表皮生长因子受体(EGFR)和 Kirsten 大鼠肉瘤病毒癌基因(KRAS)突变之间的关联。
Pathology. 2016 Jan;48(1):17-24. doi: 10.1016/j.pathol.2015.11.002. Epub 2015 Dec 12.
7
[Correlation between the new lung adenocarcinoma classification and epidermal growth factor receptor mutation].[新型肺腺癌分类与表皮生长因子受体突变之间的相关性]
Beijing Da Xue Xue Bao Yi Xue Ban. 2018 Aug 18;50(4):640-644.
8
Association of IASLC/ATS/ERS Histologic Subtypes of Lung Adenocarcinoma With Epidermal Growth Factor Receptor Mutations in 320 Resected Cases.国际肺癌研究协会/美国胸科学会/欧洲呼吸学会肺腺癌组织学亚型与320例手术切除病例中表皮生长因子受体突变的相关性
Clin Lung Cancer. 2015 May;16(3):209-15. doi: 10.1016/j.cllc.2014.10.004. Epub 2014 Oct 25.
9
Correlation of EGFR mutation and histological subtype according to the IASLC/ATS/ERS classification of lung adenocarcinoma.根据国际肺癌研究协会(IASLC)/美国胸科学会(ATS)/欧洲呼吸学会(ERS)对肺腺癌的分类,分析表皮生长因子受体(EGFR)突变与组织学亚型之间的相关性。
Int J Clin Exp Pathol. 2014 Oct 15;7(11):8039-45. eCollection 2014.
10
[Relationship between EGFR Mutations and Pathological Classification and 
Specimen of Lung Adenocarcinoma].[表皮生长因子受体(EGFR)突变与肺腺癌病理分类及标本的关系]
Zhongguo Fei Ai Za Zhi. 2017 Jun 20;20(6):382-388. doi: 10.3779/j.issn.1009-3419.2017.06.03.

引用本文的文献

1
Correlation analysis on epidermal growth factor receptor (EGFR) mutations and clinicopathological characteristics in lung adenocarcinomas.肺腺癌中表皮生长因子受体(EGFR)突变与临床病理特征的相关性分析
Front Oncol. 2025 Mar 20;15:1519150. doi: 10.3389/fonc.2025.1519150. eCollection 2025.
2
Impact of histopathological subtypes on invasive lung adenocarcinoma: from epidemiology to tumour microenvironment to therapeutic strategies.组织病理学亚型对浸润性肺腺癌的影响:从流行病学到肿瘤微环境再到治疗策略
World J Surg Oncol. 2025 Feb 27;23(1):66. doi: 10.1186/s12957-025-03701-9.
3
Deep learning-based characterization of pathological subtypes in lung invasive adenocarcinoma utilizing F-deoxyglucose positron emission tomography imaging.

本文引用的文献

1
New International Association for the Study of Lung Cancer (IASLC) Pathology Committee Grading System for the Prognostic Outcome of Advanced Lung Adenocarcinoma.国际肺癌研究协会(IASLC)病理学委员会关于晚期肺腺癌预后结果的新分级系统
Cancers (Basel). 2020 Nov 18;12(11):3426. doi: 10.3390/cancers12113426.
2
Prognostic value of EGFR 19-del and 21-L858R mutations in patients with non-small cell lung cancer.表皮生长因子受体(EGFR)19号外显子缺失和21号外显子L858R突变在非小细胞肺癌患者中的预后价值
Oncol Lett. 2019 Oct;18(4):3887-3895. doi: 10.3892/ol.2019.10715. Epub 2019 Aug 6.
3
The role of osimertinib in ()-mutant non-small cell lung cancer.
基于深度学习的 F-脱氧葡萄糖正电子发射断层扫描成像在肺浸润性腺癌病理亚型特征分析中的应用。
BMC Cancer. 2024 Oct 5;24(1):1229. doi: 10.1186/s12885-024-13018-7.
4
Deep learning-based analysis of EGFR mutation prevalence in lung adenocarcinoma H&E whole slide images.基于深度学习的肺腺癌 H&E 全切片图像中 EGFR 突变频率分析。
J Pathol Clin Res. 2024 Nov;10(6):e70004. doi: 10.1002/2056-4538.70004.
5
Simultaneous Acquisition of T790M Mutation and SCLC Transformation during Targeted Therapy in EGFR-Mutated Lung Adenocarcinoma: A Rare Case Report.表皮生长因子受体突变型肺腺癌靶向治疗中同时获得 T790M 突变和小细胞肺癌转化:一例罕见病例报告。
Am J Case Rep. 2024 Jun 1;25:e943466. doi: 10.12659/AJCR.943466.
6
Clinical significance of postoperative folate receptor-positive circulating tumor cells (FR + CTCs) for long-term prognosis in patients with invasive adenocarcinoma (IAC) of the lung.术后叶酸受体阳性循环肿瘤细胞(FR+CTCs)对肺浸润性腺癌(IAC)患者长期预后的临床意义。
Thorac Cancer. 2024 May;15(13):1060-1071. doi: 10.1111/1759-7714.15288. Epub 2024 Mar 26.
7
Preoperative levels of folate receptor-positive circulating tumor cells in different subtypes of early-stage lung adenocarcinoma: Predictive value for determining extent of surgical resection.早期肺腺癌不同亚型中叶酸受体阳性循环肿瘤细胞的术前水平:对确定手术切除范围的预测价值。
Front Oncol. 2023 Apr 17;13:1119807. doi: 10.3389/fonc.2023.1119807. eCollection 2023.
8
[Advances in the Study of Invasive Non-mucinous Adenocarcinoma 
with Different Pathological Subtypes].[不同病理亚型侵袭性非黏液腺癌的研究进展]
Zhongguo Fei Ai Za Zhi. 2023 Jan 20;26(1):22-30. doi: 10.3779/j.issn.1009-3419.2022.102.51.
奥希替尼在()突变型非小细胞肺癌中的作用。 注:原文括号部分内容缺失。
J Thorac Dis. 2019 Mar;11(Suppl 3):S448-S452. doi: 10.21037/jtd.2018.11.45.
4
Mutation Detection and Its Association With Clinicopathological Characters of Lung Cancer Patients.肺癌患者的基因突变检测及其与临床病理特征的关联
World J Oncol. 2018 Nov;9(5-6):151-155. doi: 10.14740/wjon1167. Epub 2018 Nov 23.
5
Clinicopathologic characteristics and EGFR mutations in lung cancer patients aged below 45 years.45 岁以下肺癌患者的临床病理特征和 EGFR 突变。
Curr Probl Cancer. 2019 Aug;43(4):363-370. doi: 10.1016/j.currproblcancer.2018.11.003. Epub 2018 Nov 28.
6
Clinicopathologic characteristics and outcome of patients with different EGFR mutations.不同表皮生长因子受体(EGFR)突变患者的临床病理特征及预后
Asia Pac J Clin Oncol. 2019 Jun;15(3):166-171. doi: 10.1111/ajco.13072. Epub 2018 Oct 11.
7
EGFR mutation frequency in Middle East and African non-small cell lung cancer patients: a systematic review and meta-analysis.中东和非洲非小细胞肺癌患者中 EGFR 突变频率:系统评价和荟萃分析。
BMC Cancer. 2018 Sep 14;18(1):891. doi: 10.1186/s12885-018-4774-y.
8
Clinicopathological and genetic characteristics associated with brain metastases from lung adenocarcinoma and utility as prognostic factors.肺腺癌脑转移相关的临床病理及遗传学特征及其作为预后因素的作用
Oncol Lett. 2018 Oct;16(4):4243-4252. doi: 10.3892/ol.2018.9225. Epub 2018 Jul 27.
9
Incidence and characteristics of Epidermal Growth Factor Receptor (EGFR) mutation in non-small-cell lung cancer (Adenocarcinoma histology): A report of 106 patients from Kolkata.非小细胞肺癌(腺癌组织学类型)中表皮生长因子受体(EGFR)突变的发生率及特征:来自加尔各答的106例患者报告
Indian J Cancer. 2017 Jan-Mar;54(1):305-307. doi: 10.4103/ijc.IJC_239_17.
10
Associations between epidermal growth factor receptor mutations and histological subtypes of lung adenocarcinoma according to the IASLC/ATS/ERS classification in Chinese patients.表皮生长因子受体突变与中国患者 IASLC/ATS/ERS 分类肺腺癌组织学亚型的相关性。
Thorac Cancer. 2017 Nov;8(6):600-605. doi: 10.1111/1759-7714.12489. Epub 2017 Sep 20.